Drug CategoryDrugIHD Dosing

Administration Timing Around HD Session

AntibioticsCefoxitin1-2g IV QHDAdminister Post-HD

Molecular Weight    (Da)

Excreted Unchanged (%)Normal Half-Life (Hours)ESRD Half-Life (Hours)Plasma Protein Binding (%)Volume of Distribution (L/kg)Dialytic Plasma Clearance (ml/min)% Dialyzed
42780113-2341-750.21.813.7 (low flux)


  • Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA, et al. Drug Prescribing in Renal Failure. Philadelphia: American College of Physicians;2007.
  • DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL: http://www.drugbank.ca/drugs/DB01331
  • Humbert A, Fillastre J, Leroy A, Godin M, Winzum C, Humbert G. Pharmacokinetics of Cefoxitin in Normal Subjects and in Patients with Renal Insufficiency. Reviews Of Infectious Diseases 1979; 1(1), 118-26.
  • Schrogie J, Davies R, Yeb K et al. Bioavailability and pharmacokinetics of cefoxitin sodium. Journal of Antimicrobial Chemotherapy 1978; 4(Suppl B), 69-78.